Prelude Therapeutics Stock Forecast

Sell candidate since Jul 09, 2026 Loss -9.57%

The Prelude Therapeutics Incorporated stock price fell by -7.60% on the last day (Monday, 13th Jul 2026) from $4.81 to $4.44. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.26% from a day low at $4.41 to a day high of $4.73. The price has fallen in 5 of the last 10 days but is still up by 1.37% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -257 thousand shares and in total, 321 thousand shares were bought and sold for approximately $1.42 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Prelude Therapeutics Incorporated stock with a 90% probability to be traded between $3.44 and $5.41 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

PRLD Signals & Forecast

The Prelude Therapeutics Incorporated stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.88. On a fall, the stock will find some support from the long-term average at approximately $4.34. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 30, 2026, and so far it has fallen -16.70%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Prelude Therapeutics Incorporated stock

Prelude Therapeutics Incorporated finds support from accumulated volume at $4.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.320 between high and low, or 7.26%. For the last week the stock has had daily average volatility of 9.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRLD) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Prelude Therapeutics Incorporated to open at $4.53, and during the day (based on 14 day Average True Range), to move between $4.23 and $4.65, which gives a possible trading interval of +/-$0.423 (+/-10.00%) up or down from last closing price. If Prelude Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 10.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.38 (1.35%) than the resistance at $4.70 (5.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Prelude Therapeutics Incorporated stock A Buy?

Prelude Therapeutics Incorporated holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.344 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $4.53 ( 1.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk